![]() |
Up Close: Two Current P-4 Projects
Michael
J. McLeish has spent the better part of his life in re-search laboratories,
working with and for accomplished scientists. On top of that, he had a
14-year academic career at Victorian College of Pharmacy, Monash University
in Melbourne, Australia, where he mentored dozens of high-achieving professional
degree and graduate students. As such, McLeish is not easily
awed by scientific acumen. But after 18 months as the PharmD investigations
project advisor and lab partner of P-4 Brian
DeSmet, McLeish is impressed
both by DeSmets aptitude
and his attitude. In the parlance of our business, Brian has good hands,
meaning that things work for him and his results can be duplicated,
McLeish observes. He can
carry out a bench experiment as well as write it on paper. He can see
where an idea might lead and tries to extend it. He makes suggestions
about how to approach a problem without prompting. Lots of people can
do an experiment; a lot fewer can design one. Hes in the latter
class. DeSmets PharmD investigations
project was to study the catalytic action of benzaldehyde lyase, an enzyme
that uses thiamine diphosphate as a co-factor. What makes this enzyme
so intriguing is that it catalyzes a reaction to go in one direction,
while a closely related enzyme makes the reaction go in the opposite direction,
DeSmet says. That two enzymes use the same mechanism to send a reaction in opposite
directions was odd, and we didnt know how or why, explains
DeSmet. My project had less to do with explaining that difference than it
did explaining how individual amino acids affect the catalytic action
of the benzaldehyde lyase enzyme. To pinpoint these specifics, DeSmet
mutated two amino acids in the active site to see how the benzaldehyde
lyase activity differed. What he found was that the one variant had almost
no activity at all, whereas the second strain had approximately the same
activity as the wild-type (i.e., unmutated) enzyme. This showed that the
first amino acid was vital to the enzymes activity while the other
was relatively unimportant. Its uncommon even for post-docs to understand this type of
material the first time through, McLeish
says. Brian picked up the concepts very quickly. McLeish wasnt the only one
impressed. Last April, DeSmet was
one of 12 pharmacy students nationwide to receive a $5,000 Merck Company
Foundation Research Scholar Program Award, administered by the American
Association of Colleges of Pharmacy (AACP). The purpose of the Merck program
is to encourage exemplary students to enter graduate programs in the pharmaceutical
sciences. The stipend, plus an additional $500 for supplies, supports a research
project under the guidance of a faculty project advisor for a full calendar
year beginning with the 2002 summer term. DeSmets
Merck-funded research project, Mutagenic Analysis of the Norepinephrine
Binding Site in Human Phenylethanalamine N-Methyltransferase, also
being done under McLeishs tutelage, will use the techniques learned
in his PharmD project. In July, Merck will treat DeSmet
to an expenses-paid trip to Minneapolis, Minn., where he will present
his research results at a symposium held in conjunction with AACPs
Annual Meeting. As an undergraduate, I had done a two-year research project with
a professor at U-M Medical School, but theres no comparing that
project to the ones Ive done with Michael, notes DeSmet.
Ive been pleasantly surprised by my own aptitude for this
type of research. I didnt know I had it until I got into the first
project for Michael. At this point, I cant say what the broader or longer-term application will be for the skills Ive developed through the research projects Ive done as a PharmD student. Im sure Ill use them; I just dont know how yet. |
|
|
Sitemap
| Feedback
| Faculty&Staff Intranet
| University of Michigan
428 Church Street / Ann Arbor, MI 48109-1065 / (734) 764-7312 ©2003 / page last modified: Thursday, 13-Mar-2003 09:48:18 EST |